Keywords
Last Name
Institution

Paul R Skolnik MD

TitleProfessor and Chair
InstitutionUConn Health Center
DepartmentMedicine
AddressMC 3229
MC 3229
263 Farmington Avenue
Phone860-679-2715
Fax860-679-1281
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Cloherty G, Swanson P, Lucic D, Dieckhaus K, Anthony P, Cataline P, Herman C, Hackett J, Skolnik PR, Chirch L. Clinical implications of elevated HIV-1 viral load results obtained from samples stored frozen in vacutainer plasma preparation tubes. J Virol Methods. 2014 Aug; 204:91-2. PMID: 24747107.
      View in: PubMed
    2. Baranoski AS, Meuser E, Hardy H, Closson EF, Mimiaga MJ, Safren SA, Virk P, Luk R, Skolnik PR, Kumar VS. Patient and provider perspectives on cellular phone-based technology to improve HIV treatment adherence. AIDS Care. 2014 Jan; 26(1):26-32. PMID: 23742640; PMCID: PMC4418185.
    3. McInnes DK, Hardy H, Goetz MB, Skolnik PR, Brewster AL, Hofmann RH, Gifford AL. Development and field testing of an HIV medication touch screen computer patient adherence tool with telephone-based, targeted adherence counseling. J Int Assoc Provid AIDS Care. 2013 Nov-Dec; 12(6):397-406. PMID: 22968353.
      View in: PubMed
    4. Gardner LI, Marks G, Craw JA, Wilson TE, Drainoni ML, Moore RD, Mugavero MJ, Rodriguez AE, Bradley-Springer LA, Holman S, Keruly JC, Sullivan M, Skolnik PR, Malitz F, Metsch LR, Raper JL, Giordano TP. A low-effort, clinic-wide intervention improves attendance for HIV primary care. Clin Infect Dis. 2012 Oct; 55(8):1124-34. PMID: 22828593; PMCID: PMC3657526.
    5. O'Donnell MR, Coe A, Bliss C, Lee D, Tumilty S, Skolnik PR, Horsburgh CR, Cotton D, Saukkonen J. Acceptance of interferon-gamma release assay by a high-risk urban cohort. Int J Tuberc Lung Dis. 2011 Oct; 15(10):1334-9. PMID: 22283891.
      View in: PubMed
    6. Hardy H, Kumar V, Doros G, Farmer E, Drainoni ML, Rybin D, Myung D, Jackson J, Backman E, Stanic A, Skolnik PR. Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDS. 2011 Mar; 25(3):153-61. PMID: 21323532; PMCID: PMC3101947.
    7. Garg S, Hoenig M, Edwards EM, Bliss C, Heeren T, Tumilty S, Walley AY, Koziel MJ, Skolnik PR, Horsburgh CR, Cotton D. Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection. AIDS Patient Care STDS. 2011 Mar; 25(3):135-41. PMID: 21309706; PMCID: PMC3101898.
    8. Moore JO, Hardy H, Skolnik PR, Moss FH. A collaborative awareness system for chronic disease medication adherence applied to HIV infection. Conf Proc IEEE Eng Med Biol Soc. 2011; 2011:1523-7. PMID: 22254610.
      View in: PubMed
    9. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010 Dec 10; 330(6010):1551-7. PMID: 21051598; PMCID: PMC3235490.
    10. Wilkin TJ, Su Z, Krambrink A, Long J, Greaves W, Gross R, Hughes MD, Flexner C, Skolnik PR, Coakley E, Godfrey C, Hirsch M, Kuritzkes DR, Gulick RM. Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients. J Acquir Immune Defic Syndr. 2010 Aug; 54(5):470-6. PMID: 20672447; PMCID: PMC2917795.
    11. Wasan SK, Skolnik PR, Farraye FA. A 24-year-old patient with Crohn's disease starting immunosuppressive therapy: vaccination issues to consider. Clin Gastroenterol Hepatol. 2010 Dec; 8(12):1013-6. PMID: 20656060.
      View in: PubMed
    12. Wilson IB, Laws MB, Safren SA, Lee Y, Lu M, Coady W, Skolnik PR, Rogers WH. Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV. J Acquir Immune Defic Syndr. 2010 Mar; 53(3):338-47. PMID: 20048680; PMCID: PMC2832106.
    13. Nunes D, Fleming C, Offner G, Craven D, Fix O, Heeren T, Koziel MJ, Graham C, Tumilty S, Skolnik P, Stuver S, Horsburgh CR, Cotton D. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol. 2010 Jun; 105(6):1346-53. PMID: 20179698.
      View in: PubMed
    14. Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010 Jun; 105(6):1231-8. PMID: 20104218.
      View in: PubMed
    15. Su Z, Gulick RM, Krambrink A, Coakley E, Hughes MD, Han D, Flexner C, Wilkin TJ, Skolnik PR, Greaves WL, Kuritzkes DR, Reeves JD. Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211. J Infect Dis. 2009 Dec 1; 200(11):1724-8. PMID: 19874179; PMCID: PMC2783913.
    16. Hosoya N, Su Z, Wilkin T, Gulick RM, Flexner C, Hughes MD, Skolnik PR, Giguel F, Greaves WL, Coakley E, Kuritzkes DR. Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions. J Clin Microbiol. 2009 Aug; 47(8):2604-6. PMID: 19494074; PMCID: PMC2725648.
    17. Tsibris AM, Paredes R, Chadburn A, Su Z, Henrich TJ, Krambrink A, Hughes MD, Aberg JA, Currier JS, Tashima K, Godfrey C, Greaves W, Flexner C, Skolnik PR, Wilkin TJ, Gulick RM, Kuritzkes DR. Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211. Clin Infect Dis. 2009 Mar 1; 48(5):642-9. PMID: 19191652; PMCID: PMC2756462.
    18. Robbins GK, Spritzler JG, Chan ES, Asmuth DM, Gandhi RT, Rodriguez BA, Skowron G, Skolnik PR, Shafer RW, Pollard RB. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis. 2009 Feb 1; 48(3):350-61. PMID: 19123865; PMCID: PMC2676920.
    19. Mehta SD, Hall J, Greenwald JL, Cranston K, Skolnik PR. Patient risks, outcomes, and costs of voluntary HIV testing at five testing sites within a medical center. Public Health Rep. 2008 Sep-Oct; 123(5):608-17. PMID: 18828416; PMCID: PMC2496934.
    20. Nicol MQ, Mathys JM, Pereira A, Ollington K, Ieong MH, Skolnik PR. Human immunodeficiency virus infection alters tumor necrosis factor alpha production via Toll-like receptor-dependent pathways in alveolar macrophages and U1 cells. J Virol. 2008 Aug; 82(16):7790-8. PMID: 18524817; PMCID: PMC2519548.
    21. Vranceanu AM, Safren SA, Lu M, Coady WM, Skolnik PR, Rogers WH, Wilson IB. The relationship of post-traumatic stress disorder and depression to antiretroviral medication adherence in persons with HIV. AIDS Patient Care STDS. 2008 Apr; 22(4):313-21. PMID: 18338960.
      View in: PubMed
    22. Reed C, Stuver SO, Tumilty S, Nunes D, Murray JE, Graham CS, James Koziel M, Craven DE, Skolnik PR, Horsburgh CR. Predictors of treatment for hepatitis C virus (HCV) infection in drug users. Subst Abus. 2008; 29(1):5-15. PMID: 19042314.
      View in: PubMed
    23. Pott GB, Sailer CA, Porat R, Peskind RL, Fuchs AC, Angel JB, Skolnik PR, Jacobson MA, Giordano MF, Lebeaut A, Grint PC, Dinarello CA, Shapiro L. Effect of a four-week course of interleukin-10 on cytokine production in a placebo-controlled study of HIV-1-infected subjects. Eur Cytokine Netw. 2007 Jun; 18(2):49-58. PMID: 17594937.
      View in: PubMed
    24. Lu M, Safren SA, Skolnik PR, Rogers WH, Coady W, Hardy H, Wilson IB. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008 Jan; 12(1):86-94. PMID: 17577653.
      View in: PubMed
    25. Gulick RM, Su Z, Flexner C, Hughes MD, Skolnik PR, Wilkin TJ, Gross R, Krambrink A, Coakley E, Greaves WL, Zolopa A, Reichman R, Godfrey C, Hirsch M, Kuritzkes DR. Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211. J Infect Dis. 2007 Jul 15; 196(2):304-12. PMID: 17570119.
      View in: PubMed
    26. Mehta SD, Hall J, Lyss SB, Skolnik PR, Pealer LN, Kharasch S. Adult and pediatric emergency department sexually transmitted disease and HIV screening: programmatic overview and outcomes. Acad Emerg Med. 2007 Mar; 14(3):250-8. PMID: 17331918.
      View in: PubMed
    27. Wilkin TJ, Su Z, Kuritzkes DR, Hughes M, Flexner C, Gross R, Coakley E, Greaves W, Godfrey C, Skolnik PR, Timpone J, Rodriguez B, Gulick RM. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211. Clin Infect Dis. 2007 Feb 15; 44(4):591-5. PMID: 17243065.
      View in: PubMed
    28. Greenwald JL, Hall J, Skolnik PR. Approaching the CDC's guidelines on the HIV testing of inpatients: physician-referral versus nonreferral-based testing. AIDS Patient Care STDS. 2006 May; 20(5):311-7. PMID: 16706705.
      View in: PubMed
    29. Greenwald JL, Rich CA, Bessega S, Posner MA, Maeda JL, Skolnik PR. Evaluation of the Centers for Disease Control and Prevention's recommendations regarding routine testing for human immunodeficiency virus by an inpatient service: who are we missing? Mayo Clin Proc. 2006 Apr; 81(4):452-8. PMID: 16610564.
      View in: PubMed
    30. Meschi J, Crouch EC, Skolnik P, Yahya K, Holmskov U, Leth-Larsen R, Tornoe I, Tecle T, White MR, Hartshorn KL. Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication. J Gen Virol. 2005 Nov; 86(Pt 11):3097-107. PMID: 16227233.
      View in: PubMed
    31. Rostasy K, Gorgun G, Kleyner Y, Garcia A, Kramer M, Melanson SM, Mathys JM, Yiannoutsos C, Skolnik PR, Navia BA. Tumor necrosis factor alpha leads to increased cell surface expression of CXCR4 in SK-N-MC cells. J Neurovirol. 2005 Jul; 11(3):247-55. PMID: 16036804.
      View in: PubMed
    32. Perloff ES, Duan SX, Skolnik PR, Greenblatt DJ, von Moltke LL. Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro. Drug Metab Dispos. 2005 Jun; 33(6):764-70. PMID: 15764714.
      View in: PubMed
    33. Walensky RP, Losina E, Malatesta L, Barton GE, O'Connor CA, Skolnik PR, Hall JM, McGuire JF, Freedberg KA. Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts. Am J Public Health. 2005 Jan; 95(1):71-3. PMID: 15623861; PMCID: PMC1449853.
    34. Mullins C, Eisen G, Popper S, Dieng Sarr A, Sankale JL, Berger JJ, Wright SB, Chang HR, Coste G, Cooley TP, Rice P, Skolnik PR, Sullivan M, Kanki PJ. Highly active antiretroviral therapy and viral response in HIV type 2 infection. Clin Infect Dis. 2004 Jun 15; 38(12):1771-9. PMID: 15227626.
      View in: PubMed
    35. Hardy H, Skolnik PR. Enfuvirtide, a new fusion inhibitor for therapy of human immunodeficiency virus infection. Pharmacotherapy. 2004 Feb; 24(2):198-211. PMID: 14998221.
      View in: PubMed
    36. Skolnik PR. HIV therapy--what do we know, and when do we know it? N Engl J Med. 2003 Dec 11; 349(24):2351-2. PMID: 14668462.
      View in: PubMed
    37. Skolnik PR, Rabbi MF, Mathys JM, Greenberg AS. Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects. J Acquir Immune Defic Syndr. 2002 Sep 1; 31(1):1-10. PMID: 12352144.
      View in: PubMed
    38. Roubenoff R, Grinspoon S, Skolnik PR, Tchetgen E, Abad L, Spiegelman D, Knox T, Gorbach S. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men. Am J Physiol Endocrinol Metab. 2002 Jul; 283(1):E138-45. PMID: 12067854.
      View in: PubMed
    39. Tashima KT, Flanigan TP, Kurpewski J, Melanson SM, Skolnik PR. Discordant Human Immunodeficiency Virus Type 1 drug resistance mutations, including K103N, observed in cerebrospinal fluid and plasma. Clin Infect Dis. 2002 Jul 1; 35(1):82-3. PMID: 12060879.
      View in: PubMed
    40. Young AC, Mazzullo JM, Simon AR, Skolnik PR. Case report: Kaposi's sarcoma: an unusual presentation. MedGenMed. 2001 Sep 28; 3(4):8. PMID: 11698915.
      View in: PubMed
    41. Chen G, Shankar P, Lange C, Valdez H, Skolnik PR, Wu L, Manjunath N, Lieberman J. CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood. 2001 Jul 1; 98(1):156-64. PMID: 11418475.
      View in: PubMed
    42. Angel JB, Jacobson MA, Skolnik PR, Giordano M, Shapiro L, LeBeaut A, Greaves W, Fuchs AC. A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjects. AIDS. 2000 Nov 10; 14(16):2503-8. PMID: 11101061.
      View in: PubMed
    43. Shankar P, Russo M, Harnisch B, Patterson M, Skolnik P, Lieberman J. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. Blood. 2000 Nov 1; 96(9):3094-101. PMID: 11049989.
      View in: PubMed
    44. Mylonakis E, Paliou M, Sax PE, Skolnik PR, Baron MJ, Rich JD. Central nervous system aspergillosis in patients with human immunodeficiency virus infection. Report of 6 cases and review. Medicine (Baltimore). 2000 Jul; 79(4):269-80. PMID: 10941356.
      View in: PubMed
    45. Mathys JM, Melanson SM, Schiffer-Alberts DJ, Ioannidis JP, Koziel H, Skolnik PR. NF-kappa B modulates TNF-alpha production by alveolar macrophages in asymptomatic HIV-seropositive individuals. J Immunol. 2000 Feb 1; 164(3):1588-94. PMID: 10640779.
      View in: PubMed
    46. Shevitz AH, Knox TA, Spiegelman D, Roubenoff R, Gorbach SL, Skolnik PR. Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy. AIDS. 1999 Jul 30; 13(11):1351-7. PMID: 10449288.
      View in: PubMed
    47. Roubenoff R, Skolnik PR, Shevitz A, Snydman L, Wang A, Melanson S, Gorbach S. Effect of a single bout of acute exercise on plasma human immunodeficiency virus RNA levels. J Appl Physiol (1985). 1999 Apr; 86(4):1197-201. PMID: 10194203.
      View in: PubMed
    48. Silva M, Skolnik PR, Gorbach SL, Spiegelman D, Wilson IB, Fern√°ndez-DiFranco MG, Knox TA. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS. 1998 Sep 10; 12(13):1645-51. PMID: 9764784.
      View in: PubMed
    49. Mitsuyasu RT, Skolnik PR, Cohen SR, Conway B, Gill MJ, Jensen PC, Pulvirenti JJ, Slater LN, Schooley RT, Thompson MA, Torres RA, Tsoukas CM. Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patients. NV15355 Study Team. AIDS. 1998 Jul 30; 12(11):F103-9. PMID: 9708399.
      View in: PubMed
    50. Lieberman J, Skolnik PR, Parkerson GR, Fabry JA, Landry B, Bethel J, Kagan J. Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients. Blood. 1997 Sep 15; 90(6):2196-206. PMID: 9310470.
      View in: PubMed
    51. Mylonakis E, Rich J, Skolnik PR, De Orchis DF, Flanigan T. Invasive Aspergillus sinusitis in patients with human immunodeficiency virus infection. Report of 2 cases and review. Medicine (Baltimore). 1997 Jul; 76(4):249-55. PMID: 9279331.
      View in: PubMed
    52. Lee PD, Pivarnik JM, Bukar JG, Muurahainen N, Berry PS, Skolnik PR, Nerad JL, Kudsk KA, Jackson L, Ellis KJ, Gesundheit N. A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab. 1996 Aug; 81(8):2968-75. PMID: 8768860.
      View in: PubMed
    53. Wolf LE, Skolnik PR, Noble JT. Recurrent muscle abscesses in a patient with HIV infection: beware the Baron von Munchausen. AIDS. 1996 Jun; 10(6):685-7. PMID: 8780830.
      View in: PubMed
    54. Perales MA, Skolnik PR, Lieberman J. Effect of interleukin 12 on in vitro HIV type 1 replication depends on clinical stage. AIDS Res Hum Retroviruses. 1996 May 20; 12(8):659-68. PMID: 8744576.
      View in: PubMed
    55. Granowitz EV, Saget BM, Angel JB, Wang MZ, Wang A, Dinarello CA, Skolnik PR. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Apr 15; 11(5):430-7. PMID: 8605587.
      View in: PubMed
    56. Ioannidis JP, Cappelleri JC, Lau J, Sacks HS, Skolnik PR. Predictive value of viral load measurements in asymptomatic untreated HIV-1 infection: a mathematical model. AIDS. 1996 Mar; 10(3):255-62. PMID: 8882664.
      View in: PubMed
    57. Ioannidis JP, Cappelleri JC, Skolnik PR, Lau J, Sacks HS. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. Arch Intern Med. 1996 Jan 22; 156(2):177-88. PMID: 8546551.
      View in: PubMed
    58. Ioannidis JP, Reichlin S, Skolnik PR. Long-term productive human immunodeficiency virus-1 infection in human infant microglia. Am J Pathol. 1995 Nov; 147(5):1200-6. PMID: 7485383; PMCID: PMC1869535.
    59. Angel JB, Saget BM, Walsh SP, Greten TF, Dinarello CA, Skolnik PR, Endres S. Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication. AIDS. 1995 Oct; 9(10):1137-44. PMID: 8519449.
      View in: PubMed
    60. Granowitz EV, Saget BM, Wang MZ, Dinarello CA, Skolnik PR. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Mol Med. 1995 Sep; 1(6):667-77. PMID: 8529133; PMCID: PMC2229977.
    61. Wynia MK, Shapiro B, Kuvin JT, Skolnik PR. Fatal Castleman's disease and pulmonary Kaposi's sarcoma in an HIV-seropositive woman. AIDS. 1995 Jul; 9(7):814-6. PMID: 7546432.
      View in: PubMed
    62. Ioannidis JP, Cappelleri JC, Lau J, Skolnik PR, Melville B, Chalmers TC, Sacks HS. Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illness. Ann Intern Med. 1995 Jun 1; 122(11):856-66. PMID: 7741372.
      View in: PubMed
    63. Ioannidis JP, Skolnik PR, Chalmers TC, Lau J. Human leukocyte antigen associations of epidemic Kaposi's sarcoma. AIDS. 1995 Jun; 9(6):649-51. PMID: 7662207.
      View in: PubMed
    64. Angel JB, Saget BM, Wang MZ, Wang A, Dinarello CA, Skolnik PR. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism. J Interferon Cytokine Res. 1995 Jun; 15(6):575-84. PMID: 7553227.
      View in: PubMed
    65. Lieberman J, Fabry JA, Shankar P, Beckett L, Skolnik PR. Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects. AIDS Res Hum Retroviruses. 1995 Feb; 11(2):257-71. PMID: 7742040.
      View in: PubMed
    66. Collier AC, Coombs RW, Fischl MA, Skolnik PR, Northfelt D, Boutin P, Hooper CJ, Kaplan LD, Volberding PA, Davis LG, Henrard DR, Weller S, Corey L. Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection. Ann Intern Med. 1993 Oct 15; 119(8):786-93. PMID: 8379600.
      View in: PubMed
    67. Margalith M, Medina DJ, Hsiung GD, Smith BR, D'Aquila RT, Kaplan JC, Bechtel L, Wang MZ, Skolnik PR, Hirsch MS. Interactions between HIV-1 and cytomegalovirus in human osteosarcoma cells carrying both viruses. AIDS Res Hum Retroviruses. 1993 Jun; 9(6):519-27. PMID: 8394095.
      View in: PubMed
    68. Chupp GL, Alroy J, Adelman LS, Breen JC, Skolnik PR. Myositis due to Pleistophora (Microsporidia) in a patient with AIDS. Clin Infect Dis. 1993 Jan; 16(1):15-21. PMID: 8448294.
      View in: PubMed
    69. Granowitz EV, Donaldson WR, Skolnik PR. Gas-forming soft tissue abscess caused by Streptococcus pneumoniae. Am J Med. 1992 Jul; 93(1):105-7. PMID: 1626559.
      View in: PubMed
    70. Skolnik PR. Treatment of CMV retinitis. N Engl J Med. 1992 Jun 18; 326(25):1701; author reply 1702-3. PMID: 1317010.
      View in: PubMed
    71. Lieberman J, Fabry JA, Kuo MC, Earl P, Moss B, Skolnik PR. Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase. J Immunol. 1992 May 1; 148(9):2738-47. PMID: 1374097.
      View in: PubMed
    72. Skolnik PR, Jahn B, Wang MZ, Rota TR, Hirsch MS, Krane SM. Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25-dihydroxycholecalciferol. Proc Natl Acad Sci U S A. 1991 Aug 1; 88(15):6632-6. PMID: 1650477; PMCID: PMC52142.
    73. Mello KA, Wheat LJ, Lis R, Donnelly B, Skolnik PR. Ketoconazole-responsive tonsillar infection due to Histoplasma capsulatum in an HIV-1-seropositive individual. AIDS. 1991 Jul; 5(7):908-10. PMID: 1892607.
      View in: PubMed
    74. Skolnik PR, Kosloff BR, Bechtel LJ, Huskins KR, Flynn T, Karthas N, McIntosh K, Hirsch MS. Absence of infectious HIV-1 in the urine of seropositive viremic subjects. J Infect Dis. 1989 Dec; 160(6):1056-60. PMID: 2511253.
      View in: PubMed
    75. Skolnik PR, Pomerantz RJ, de la Monte SM, Lee SF, Hsiung GD, Foos RY, Cowan GM, Kosloff BR, Hirsch MS, Pepose JS. Dual infection of retina with human immunodeficiency virus type 1 and cytomegalovirus. Am J Ophthalmol. 1989 Apr 15; 107(4):361-72. PMID: 2539019.
      View in: PubMed
    76. D'Amico DJ, Skolnik PR, Kosloff BR, Pinkston P, Hirsch MS, Schooley RT. Resolution of cytomegalovirus retinitis with zidovudine therapy. Case report. Arch Ophthalmol. 1988 Sep; 106(9):1168-9. PMID: 2843155.
      View in: PubMed
    77. Skolnik PR, Kosloff BR, Hirsch MS. Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J Infect Dis. 1988 Mar; 157(3):508-14. PMID: 2830343.
      View in: PubMed
    78. Yankner BA, Skolnik PR, Shoukimas GM, Gabuzda DH, Sobel RA, Ho DD. Cerebral granulomatous angiitis associated with isolation of human T-lymphotropic virus type III from the central nervous system. Ann Neurol. 1986 Sep; 20(3):362-4. PMID: 3639720.
      View in: PubMed
    79. Cox A, Lisak RP, Skolnik P, Zweiman B. Effect of thymectomy on blood T-cell subsets in myasthenia gravis. Ann Neurol. 1986 Mar; 19(3):297-8. PMID: 3485953.
      View in: PubMed
    80. Skolnik PR, Lisak RP, Zweiman B. Monoclonal antibody analysis of blood T-cell subsets in myasthenia gravis. Ann Neurol. 1982 Feb; 11(2):170-6. PMID: 6462101.
      View in: PubMed
    Skolnik's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _